The Covid-19 vaccine in the United States is expected to be available by November 1, 2020.
However, experts are calling for complete data on the vaccine before it is actually distributed, as clinical trials are being carried out quite quickly and are unprecedented.
The American Centers for Disease Control and Prevention’s (CDC) response to states to prepare for large-scale distribution of the vaccine by November 1 sparked concerns that political pressure could override commitments to safety.
Making the vaccine ready for distribution, as well as selecting groups of high-risk people or frontline health care workers in November will depend on phase 3 clinical trials that begin enrolling human volunteers in July.
According to Paul Offit, director of the Center for Vaccine Education at Children’s Hospital of Philadelphia, it is possible that the Data and Safety Monitoring Board, which is run by the National Institutes of Health, could stop trials earlier if the vaccine did work.
Doctors will insist on looking at the complete data set and demand that the information comes from people who are in the scientific community.
Cleveland Clinic cardiologist Steven Nissen wants scientists or doctors to make these decisions, not political leaders.
New York Governor Andrew Cuomo said he was suspicious of any vaccines due to be launched in early November.
Large-scale clinical trials are needed to show that the vaccine is actually being tested on tens of thousands of volunteers in America.
However, all they did was clinical trials on 150 people to show that a vaccine was effective.